Key Training Schemes
In Collaboration with Capital City College Group, Richmond Pharmacology have created pathway opportunities for apprentices to join our Clinical Operations Department where they will combine on the job training with a BTEC Level 2 Healthcare Assistant Practitioner course. Specifying in a range of Knowledge, Skills and Behaviours that together form the Core Competencies of the role. Apprentices are assessed by an Independent Assessment Organisation (IAO) as End Pont Assessor (EPA), using different methods to demonstrate competence in various areas including clinical care, research, innovation and more.
Richmond Pharmacology are involved in the launch of a new Level 7 Clinical Pharmacology Scientist integrated MSc apprentice scheme. The scheme was set in motion by the Clinical Pharmacology Skills Alliance of which Richmond Pharmacology is a member. It is aimed at addressing a shortage of qualified clinical pharmacologists in the industry and raising a profile of this career by providing a 3 year structured training development program awarded as an MSc after successful completion.
The Richmond Pharmacology Clinical Research Scientist (CRS) rotation is a 3-year post-graduate Training Program designed to provide life science graduates with comprehensive on the job learning experience linking theory with practice. This program gives robust hands-on application of clinical research management within a number of key departments at Richmond Pharmacology. The program consists of six compulsory 6-monthly modules within the key departments including clinical project management, clinical operations and data science. At the end of the rotation, the CRS will be adequately equipped to occupy management positions within the company or industry-wide.
Richmond Pharmacology’s London Bridge Unit is an accredited Resuscitation Council UK Course Center. We provide small group sessions, for maximum results, to our clinical staff as well as external candidates, in the areas of resuscitation and Immediate Life Support.
Richmond Pharmacology deliver the ultrasound guided cannulation course (UGC) for its clinical healthcare professionals, to fully utilize ultrasound technology to aid venous cannulation of difficult peripheral veins. The course structure is lecture based, with small group practical sessions and assessments.
Richmond Pharmacology deliver BSE L1 training for its Research Physicians and Resuscitation Practitioners, at BSE level 1. Level 1 accreditation allows rapid bedside echocardiographic assessment of the acutely unwell patient and was launched in April 2018 in response to and in anticipation of the Department of Health mandate for 24/7 provision of emergency echo services. The accreditation process comprises a logbook component of 75 cases collected over a period of 12 months and demonstrating a range of acute pathology, followed by an assessment process which aims to assess technical ability, experience and image interpretation.
The purpose of specialty training in pharmaceutical medicine is to produce accredited pharmaceutical physicians, who are equipped with specialist knowledge and comprehensive skills and competencies to practise to the highest ethical and professional standards, for the benefit and safety of patients and the public, in the development and maintenance of medicines.
The practical training comprises a modular programme in 6 fields of practice in pharmaceutical medicine that accompanies and / or follows acquisition of the specialty knowledge base. The 6 operational modules are Medicines Regulation, Clinical Pharmacology, Statistics and Data Management, Clinical Development, Healthcare Marketplace and Drug Safety Surveillance.
I am very pleased with the Project Management of both studies undertaken on behalf of (blank) and any future studies we have to outsource will automatically be contracted to you.
Many thanks for your time today, most impressed with the quality of the follow up to our enquiry.
Please know that it has been an absolute pleasure collaborating with you and that I am most appreciative of the key contributions RPL has made to this project thus far. I hope I have the opportunity to work with RPL again in the very near future.
Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we areRead more ›
The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophreniaRead more ›
Richmond Pharmacology have developed a resourceful way to use study equipment to help reduce waste produced on siteRead more ›